Multilateral and bilateral donors generally intend for economic development aid to recipient countries to decrease over time and for those countries to move toward greater self-sufficiency. Recent EPAR research looks at whether the concept of "self-sufficiency" for aid recipient countries is defined in the academic literature, grey literature, and donor policy documents.
Private sector investment in overall health research and development (R&D) exceeds $150 billion annually, but only $5.9 billion of this is focused on global health diseases that primarily affect low- and middle-income countries (LMICs). A recent EPAR review examines the evidence in the literature for five hypothesized disincentives to private sector investment in global health R&D, and looks at examples of policy incentives that may help promote private sector investment.
EPAR reviewed the literature on factors affecting private sector investment in global health R&D. Partnerships are common across all phases of preclinical and clinical research. Both within the private sector and spanning the private, public, and philanthropic sectors, partnerships are generally seen as effective mechanisms to overcome research disincentives and increase private investment in global health R&D.
Cash transfer programs have become an increasingly common tool used in low- and middle- income countries to promote investments in education, improve health outcomes, and combat poverty. EPAR conducted “a review of reviews”, with an emphasis on reported evidence of long-term impacts of cash transfer programs.